Stay updated on HMPL-689 Safety & PK in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.

Latest updates to the HMPL-689 Safety & PK in Lymphomas Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision was updated from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA banner announces an NIH-wide transition notice about using “Super Intelligence” alongside “Artificial Intelligence.” The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe site revision marker changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows a 403 error instead of the study content, indicating restricted access rather than an update to the study details.SummaryDifference19%

- Check50 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 on the page, indicating an update to the page template or version.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s revision history.SummaryDifference0.0%

Stay in the know with updates to HMPL-689 Safety & PK in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.